The article by Zabini and colleagues (1), published in the January 15, 2018, issue of the Journal, omitted mention of the project number for one of the funding sources; the relevant sentence should read: “Supported by the Erwin-Schroedinger Fellowship of the Austrian FWF Foundation (D.Z.; J3603), and grants-in-aid from the Canadian Institutes of Health Research and the Heart and Stroke Foundation of Canada (W.M.K.).”
Reference
- 1.Zabini D, Granton E, Hu Y, Miranda MZ, Weichelt U, Breuils Bonnet S, Bonnet S, Morrell NW, Connelly KA, Provencher S, Ghanim B, Klepetko W, Olschewski A, Kapus A, Kuebler WM. Loss of SMAD3 promotes vascular remodeling in pulmonary arterial hypertension via MRTF disinhibition. Am J Respir Crit Care Med. 2018;197:244–260. doi: 10.1164/rccm.201702-0386OC. [DOI] [PubMed] [Google Scholar]